PE Acquisition of Molecular Informatics Puts MDL Out of Bioinformatics Market | GenomeWeb

SAN LEANDRO, Calif.--MDL Information Systems here, which sold its rights to market Molecular Informatics' BioMerge bioinformatics software after the latter company was acquired recently by Perkin-Elmer, has essentially left the bioinformatics market for the time being, officials told BioInform. However, the firm will continue to work in the broader biology and chemistry arenas and could return to bioinformatics with software offerings--probably of a more custom nature--at some point in the future, according to Peter Cohan, MDL's vice-president of customer marketing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.